RANI
Rani Therapeutics Powers Ahead with Record-Breaking Q4 Results, Fueling Pipeline Growth and Platform Expansion
Renowned biotech company Rani Therapeutics has made headlines with its stunning fourth-quarter financial results for 2025. The clinical-stage biotherapeutics powerhouse has taken significant strides in advancing and validating the revolutionary Rani Pill platform across multiple therapeutic modalities, while bolstering its financial position and expanding strategic partnerships. As revealed during the